Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Burch
Andre Burch, Bachenbuelach CH
| Patent application number | Description | Published |
|---|---|---|
| 20090306738 | ELONGATED IMPLANT HAVING AN EXTERNAL ENERGY COUPLING - Electrotherapeutic implant for stimulation of body tissue, comprising at least two electrode poles ( | 12-10-2009 |
Herbert Burch, Cham CH
| Patent application number | Description | Published |
|---|---|---|
| 20100137574 | SYSTEM AND METHOD FOR THE AUTOMATED EXTRACTION OF NUCLEIC ACIDS - A system and method for the automated extraction of nucleic acids from nucleic acids containing samples are disclosed. In the system, reagents provided in cavities of a reagent plate are transferred to samples accommodated in a process plate using a pipetting device comprising pipettes provided with disposable pipette tips for pipetting of the reagents to obtain sample-reagent mixtures, the sample-reagent mixtures accommodated in the process plate are incubated by an incubating device to release the nucleic acids; the released nucleic acids accommodated in the process plate are separated by a separating device and released to obtain extracted nucleic acids containing fluids; the extracted nucleic acids containing fluids are transferred to cavities of an output plate by disposable pipette tips; wherein each of the samples is assigned one-to-one to a cavity of the reagent plate, at least one of the disposable pipette tips and a cavity of the output plate. | 06-03-2010 |
Jason Burch, Westmount CA
| Patent application number | Description | Published |
|---|---|---|
| 20090099226 | Quinoline derivatives as ep4 antagonists - The invention is directed to quinoline derivatives as prostaglandin E type receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. The derivatives have the following structure of formula (I): wherein A and B represents either a nitrogen atom or a CH group with the proviso that they cannot both simultaneously be CH, Q can represent a nitrogen or a carbon atom, and Y and Z are either a nitrogen atom, a N(O) group or a C(R | 04-16-2009 |
| 20090247596 | THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS - The invention is directed to thiophenecarboxamide derivatives of formulae I and II as EP4 receptor ligands, antagonists or agonists, useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, cancer and glaucoma. Pharmaceutical compositions and methods of use are also included. (Formulas I and II). | 10-01-2009 |
| 20100105718 | NAPHTHALENE AND QUINOLINE SULFONYLUREA DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS - The invention is directed to naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutical compositions and methods of use are also included. | 04-29-2010 |
Nicholas Burch, Oxfordshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100292921 | MODE OF TRANSPORT DETERMINATION - A method of determining a mode of transport for a portion of a user's journey is described. The method comprises: receiving, at a portable device being carried by a user, position data for current locations of the user over a period of time; determining, from the position data, a characteristic of the speed for the journey portion; identifying possible modes of transport on the basis of pre-established ranges of speed characteristics for particular modes of transport; and selecting a most likely mode of transport from the identified possible modes of transport based on the proximity of the user's position data to known public transport nodes. The method can also be used to determine the carbon footprint of a user using a portable device. | 11-18-2010 |
William Martin Burch, Gymea Bay AU
| Patent application number | Description | Published |
|---|---|---|
| 20110002847 | METHOD OF FORMING AN INJECTABLE RADIOACTIVE COMPOSITION OF A CARBON ENCAPSULATED RADIOACTIVE PARTICULATE - A method of forming an injectable radioactive composition, the method comprising the steps of: (a) depositing a solid form of technetium onto a carbon crucible; (b) preheating the solid form of technetium to remove any carrier; (c) plasma ablating the technetium and portions of the carbon crucible; (d) allowing the carbon and technetium metal to co-condense from the gas phase to produce a nanoparticle composite aerosol in an inert gas; (e) dispersing the nanoparticle composite in water containing a low concentration of surfactant using an electrostatic precipitator; (f) size fractionating the nanoparticle dispersion by filtration with hydrophilic membranes of known pore size. | 01-06-2011 |